Baytacare Pharmaceutical Co., Ltd. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was CNY 0 compared to CNY 7.097 million a year ago. Net loss was CNY 2.068 million compared to CNY 5,000 a year ago. Basic loss per share was CNY 0.0024 compared to Basic EPS of CNY 0 a year ago. Basic loss per share from continuing operations was CNY 0.0024 compared to Basic EPS - Continuing Operations of CNY 0 a year ago. For the half year, sales was CNY 7.212 million compared to CNY 7.097 million a year ago. Net loss was CNY 3.549 million compared to CNY 8.348 million a year ago. Basic loss per share was CNY 0.0041 compared to CNY 0.0097 a year ago.